Proposed changes to the statutory scheme to control the costs of branded health service medicines

The government is consulting on proposed changes to legislation to ensure that the overall growth of branded medicines sales made to the NHS by pharmaceutical manufacturers in the statutory medicines pricing scheme remains at a sustainable level.

Source: NHS Networks - August 13, 2018 Category: UK Health Source Type: news